Aligos launches voluntary option exchange program for underwater stock options

Aligos Therapeutics, Inc.

Eligible options have exercise price >= $2.10, granted under 2020 plan, held by US/Switzerland employees or directors.
Replacement options cover fewer shares per specified exchange ratios and are subject to new vesting schedule.
Program not yet commenced; final terms to be announced via Schedule TO tender offer.
Education session for eligible participants scheduled for January 30, 2024 at 2:00 pm PT.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.